[
  {
    "question": "Scenario with attached Angio (suggestive of FM-DYSPLASIA) what to do:",
    "option_a": "Renal angio",
    "option_b": "Alpha 1 antitrypsin",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Fibromuscular dysplasia (FMD) is a nonatherosclerotic, noninflammatory arteriopathy affecting medium\u2010sized arteries, most classically the renal and carotid arteries. Its angiographic hallmark is the 'string-of-beads' appearance. When an angiogram \u2014 even if originally obtained from a cerebrovascular source \u2014 is suggestive of FMD, it is important to examine other vascular beds that may be involved. FMD is believed to result from abnormal cellular proliferation within the arterial wall (most commonly the media), leading to alternating areas of stenosis and aneurysmal dilatation. Although the exact cause remains unclear, hormonal factors (given its predilection for middle\u2010aged women) and genetic factors are thought to contribute. This multifocal vascular involvement means that both cerebral and renal arteries can be affected. Clinically, FMD may present with symptoms related to cerebrovascular events (such as transient ischemic attacks or strokes if the carotid arteries are involved) or with renovascular hypertension if the renal arteries are affected. The finding on a cerebral angiogram consistent with FMD should prompt an evaluation for concomitant renal artery involvement, which can have significant implications in blood pressure management. The initial diagnosis is usually made by imaging \u2013 typically using duplex ultrasound, CT angiography, MR angiography, or catheter-based digital subtraction angiography. Differential diagnoses include atherosclerotic disease (which tends to produce smooth, concentric stenoses without the beadlike pattern) and vasculitis (which would show inflammatory signs both clinically and on laboratory work-up). Once FMD is suspected in one vascular bed, further evaluation (such as a renal angiogram) is warranted. Management focuses on controlling blood pressure and mitigating stroke risk. In cases with significant renal artery involvement, percutaneous transluminal angioplasty may be recommended. First-line treatments include risk factor modification and medical management with antihypertensives. In pregnant or lactating women, blood pressure control is crucial and agents such as labetalol or methyldopa (which have better safety profiles in pregnancy) should be considered. Secondary interventional procedures are reserved for severe or refractory cases. Option A, 'Renal angio,' is appropriate because once FMD is suspected (based on the cerebral angiogram in this scenario), imaging of the renal arteries is indicated to assess possible multisystem involvement. Option B (Alpha 1 antitrypsin) is unrelated, as it pertains to a genetic deficiency primarily linked to lung and liver disease. Options C and D are not provided. 1) FMD predominantly affects middle-aged women and is often discovered incidentally or after investigation of a stroke or hypertension. 2) The 'string-of-beads' sign on angiography is pathognomonic. 3) Once FMD is diagnosed in one vascular territory, evaluation for additional involvement (especially of the renal arteries) is essential. Recent guidelines and consensus statements from vascular and radiologic societies recommend a comprehensive vascular workup in patients with FMD. Advances in non-invasive imaging techniques allow for earlier and more accurate detection, which in turn informs risk factor management and the need for possible revascularization procedures.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of lateral medullary:",
    "option_a": "PICA",
    "option_b": "no vertebral artery in options",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Lateral medullary syndrome, also known as Wallenberg syndrome, is a classic brainstem stroke syndrome that affects the lateral portion of the medulla oblongata. It is most commonly related to ischemia in the territory of the Posterior Inferior Cerebellar Artery (PICA). An occlusion of the PICA leads to infarction in the lateral medulla. This infarction compromises multiple neural structures including the vestibular nuclei, spinal trigeminal nucleus, nucleus ambiguus, and sympathetic pathways. The resultant deficits reflect the loss of these structures\u2019 functions. Patients typically present with sudden onset of vertigo, nausea, vomiting, dysphagia, hoarseness, ipsilateral facial hypoalgesia (loss of pain and temperature sensation), and contralateral body sensory deficits for pain and temperature. These constellation of symptoms are pathognomonic for lateral medullary syndrome due to PICA occlusion. Diagnosis is made clinically and confirmed with neuroimaging (CT/MRI) showing infarction in the lateral medulla. Vascular imaging (CTA, MRA, or catheter angiography) can identify the occluded vessel. Differential diagnoses include lateral pontine syndrome (often due to AICA occlusion) and other posterior circulation strokes, which can be differentiated based on both imaging and the specific neurological deficits present. Acute management follows standard stroke care with consideration for intravenous thrombolytic therapy if the patient presents within the appropriate window. Secondary prevention includes the use of antiplatelet agents and management of vascular risk factors. In pregnancy, special care must be taken when considering thrombolysis \u2013 weighing maternal benefits against fetal risks \u2013 and medications with proven safety profiles should be selected. Option A, 'PICA,' is the correct choice because occlusion of the Posterior Inferior Cerebellar Artery is the most frequent cause of lateral medullary syndrome. Option B mentioning the 'no vertebral artery in options' distracts from the core pathology. Options C and D are not provided. 1) Lateral medullary syndrome is characterized by a cross-sensory deficit (ipsilateral facial, contralateral body pain/temperature loss). 2) Occlusion of the PICA is the prototypical cause of this syndrome. 3) Early recognition is crucial for timely intervention, particularly regarding acute stroke management. Current guidelines emphasize rapid neuroimaging and prompt initiation of acute stroke therapies. Recent studies support the use of advanced imaging techniques that enhance early detection of posterior circulation strokes, and further refine selection criteria for thrombolytic or endovascular therapies even in the complex anatomical region of the brainstem.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "CSF finding in RCVS:",
    "option_a": "slightly high protein",
    "option_b": "other choices was clearly wrong",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Reversible Cerebral Vasoconstriction Syndrome (RCVS) is characterized by sudden, severe ('thunderclap') headaches and segmental constriction of cerebral arteries that is reversible over time. It typically lacks the inflammatory or infectious changes seen in other CNS vasculopathies. RCVS is thought to result from transient disturbances in the regulation of cerebral arterial tone. This leads to multifocal vasoconstriction without the accompanying blood\u2013brain barrier disruption or significant inflammatory response that one would see in infections or primary angiitis of the central nervous system. Clinically, patients with RCVS present with recurrent thunderclap headaches. Neurological deficits may arise if the vasoconstriction results in ischemic injury. Since the underlying process is noninflammatory, CSF studies are typically normal or near-normal. The workup includes careful neuroimaging (CT, MRI, MRA, or catheter angiography) to document the segmental vasoconstriction and repeat studies to confirm reversibility. A lumbar puncture is performed primarily to exclude subarachnoid hemorrhage or CNS vasculitis. Differential diagnoses include subarachnoid hemorrhage, primary angiitis of the CNS (which usually shows pleocytosis and a more marked protein elevation), and central nervous system infections. First-line management generally includes calcium channel blockers (such as nimodipine) to help relieve vasoconstriction and supportive care including pain management. Avoidance of triggers (e.g., vasoactive substances like serotonergic drugs) is also recommended. In pregnant or lactating patients, the use of medications must be carefully considered; agents with more favorable safety profiles (and consultation with maternal\u2013fetal medicine) are preferred. Option A, 'slightly high protein,' is acceptable in this context. Although RCVS is classically associated with normal CSF, minor nonspecific protein elevation (without significant pleocytosis) can occasionally be observed. The other options (not detailed here) are clearly less representative of the typical CSF findings in RCVS. 1) RCVS is best known for its thunderclap headaches and reversible vascular changes on imaging. 2) The CSF in RCVS is typically normal or nearly normal, which helps distinguish it from inflammatory vasculopathies such as primary angiitis of the CNS. 3) Prompt recognition and differentiation from other causes of severe headache are critical to prevent complications. Recent studies have confirmed that mild CSF protein elevation (if present) in RCVS does not indicate an inflammatory process. Emerging research continues to refine diagnostic criteria and optimal management strategies for RCVS, emphasizing the importance of multimodal imaging and careful clinical monitoring.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about CADASIL:",
    "option_a": "CADASIL",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "CADASIL stands for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. It is a hereditary small vessel disease caused by mutations in the NOTCH3 gene, leading to distinctive clinical and radiographic features. The disease is caused by mutations in the NOTCH3 gene, which lead to abnormal accumulation of granular osmiophilic material in the smooth muscle cells of small arteries. This accumulation results in progressive arteriopathy, with consequent subcortical infarcts and white matter changes. The pathophysiological process underpins the clinical signs of migraine, recurrent strokes, and cognitive decline. Patients with CADASIL typically present in early to mid-adulthood with migraine (often with aura), recurrent lacunar strokes, mood disturbances, and a progressive subcortical dementia. MRI findings classically reveal white matter hyperintensities involving the periventricular areas and the anterior temporal lobes. The diagnosis of CADASIL is based on a characteristic clinical picture, typical MRI findings, and can be confirmed with genetic testing for NOTCH3 mutations. A skin biopsy demonstrating granular osmiophilic material can also support the diagnosis. Differential diagnoses include other causes of small vessel disease and leukoencephalopathies such as multiple sclerosis or vascular dementia, which can be distinguished based on imaging, family history, and specific clinical features. There is no curative treatment for CADASIL, so management is primarily supportive. This includes aggressive control of vascular risk factors (such as hypertension and hyperlipidemia), antiplatelet therapy for secondary stroke prevention, and symptomatic management of migraines and mood disturbances. Genetic counseling is crucial for affected individuals and family members. In pregnant or lactating women, special attention to blood pressure control and medication safety is required, with agents selected based on their safety profile in pregnancy (e.g., labetalol for hypertension). Option A, 'CADASIL,' is the correct answer as it directly names the condition characterized by the clinical and radiological features described in the scenario. The other options, which are not provided in this context, do not align with the classic findings of CADASIL. 1) CADASIL should be suspected in patients with a history of migraine with aura, subcortical strokes, and a family history of early-onset dementia or stroke. 2) The anterior temporal pole involvement on MRI is highly suggestive of CADASIL. 3) Genetic confirmation is key for diagnosis and family counseling. Recent advances emphasize the importance of genetic testing for NOTCH3 mutations in patients with suspected CADASIL. While no disease-modifying treatments exist, ongoing research is focused on potential targeted therapies. Current guidelines stress the importance of risk factor management and genetic counseling to optimize long-term outcomes.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Common question, SCENARIO about progressive symptoms of spinal fistula with attached MRI for spine:",
    "option_a": "DAVF",
    "option_b": "Cavernoma",
    "option_c": "AVM",
    "option_d": "AVF best fits the clinical scenario of progressive symptoms related to a spinal fistula.",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Spinal dural arteriovenous fistula (DAVF) is the most common type of spinal vascular malformation. It involves an abnormal connection between a dural artery and a bridging medullary vein, leading to venous congestion and progressive myelopathy. In DAVF, arterial blood is shunted directly into the venous system without the normal capillary bed. This results in elevated venous pressure, impaired venous drainage, and subsequent spinal cord ischemia. The resulting venous congestion leads to chronic spinal cord edema and neurological deficits. Patients with spinal DAVF typically present with slowly progressive weakness and sensory disturbances in the lower extremities, along with gait abnormalities. The condition is most commonly seen in middle-aged to elderly males. MRI findings often reveal hyperintensity on T2-weighted images in the spinal cord (indicative of edema) and serpiginous flow voids representing dilated vessels. Initial assessment with MRI of the spine is essential, as it can suggest the diagnosis by showing cord edema and abnormal flow voids. However, spinal angiography remains the gold standard for definitive diagnosis, allowing precise localization and characterization of the fistula. Differential diagnoses include intramedullary arteriovenous malformations (AVMs) and cavernomas, but these have differing clinical and imaging features. The treatment of spinal DAVF typically involves endovascular embolization or microsurgical disconnection to interrupt the abnormal shunt. In pregnant patients or those who are lactating, careful risk\u2013benefit assessment is necessary as angiographic procedures involve radiation and contrast agents, which may be deferred or managed with modifications based on current guidelines. Multidisciplinary management is crucial to optimize neurological outcomes. The options provided were DAVF, cavernoma, and AVM. Cavernomas are usually benign vascular lesions that may present with hemorrhages but do not lead to venous congestion as seen in DAVF. Intramedullary AVMs often present with hemorrhage rather than the progressive myelopathic symptoms typical of DAVF. Thus, the option DAVF best fits the clinical scenario of progressive symptoms related to a spinal fistula. Early recognition of spinal DAVF is essential as treatment can prevent irreversible spinal cord damage. Clues on MRI such as cord signal hyperintensity and flow voids should lead to angiographic confirmation. A multidisciplinary approach, including neurosurgery and interventional neuroradiology, is recommended. Current guidelines support endovascular embolization as a first-line treatment for spinal DAVF when feasible, with surgical intervention as an alternative in selected cases. Recent studies emphasize the importance of early intervention to halt progression of myelopathy and improve long-term outcomes. Special considerations for pregnant or lactating patients include minimizing fetal radiation exposure and using alternative imaging modalities or protective measures when necessary.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "a woman who was being investigated for stroke, was found to have high titer of anti-beta II glycoprotein AB, and anticardiolipin AB. She was diagnosed with antiphospholipid syndrome. she has a history of a prior LL DVT, a small PFO was also found. what is the appropriate management?",
    "option_a": "DAPT",
    "option_b": "warfarin",
    "option_c": "closure of PFO",
    "option_d": "ASA",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the formation of antibodies against phospholipid-binding proteins (notably anticardiolipin and anti-beta2 glycoprotein I). These antibodies predispose patients to both arterial and venous thrombotic events. In this case, the patient\u2019s history, including a prior lower limb DVT and a stroke, is consistent with thrombotic manifestations of APS. In APS, the autoantibodies induce a hypercoagulable state by activating endothelial cells, platelets, and complement pathways, while interfering with the natural anticoagulant mechanisms. This results in an increased risk for clot formation in both the arterial and venous systems. The presence of high titers of anticardiolipin and anti-beta2 glycoprotein I antibodies confirms the autoimmune-mediated coagulation dysregulation. Patients with APS frequently present with recurrent thrombotic events such as DVTs and cerebrovascular accidents (strokes), as seen in this patient. Although a small patent foramen ovale (PFO) was incidentally detected, the hypercoagulable state from APS is the primary concern, and the PFO does not change the management approach in this context. The diagnosis of APS is based on the revised Sapporo criteria (or Sydney criteria), which require: 1) a clinical history of vascular thrombosis and/or pregnancy morbidity, and 2) laboratory confirmation of antiphospholipid antibodies (anticardiolipin, anti-beta2 glycoprotein I, or lupus anticoagulant) on two or more occasions at least 12 weeks apart. Differential diagnoses include other hypercoagulable disorders such as inherited thrombophilias, malignancy-related thrombosis, and other autoimmune disorders like systemic lupus erythematosus. Long-term anticoagulation is the cornerstone of management in APS patients with prior thrombotic events. Warfarin is the anticoagulant of choice in nonpregnant patients, with a target INR of 2-3 under standard circumstances. For women who are pregnant or lactating, warfarin is contraindicated due to its teratogenicity, and the recommended management is with low molecular weight heparin (LMWH) combined with low-dose aspirin. Option A (DAPT) and Option D (ASA) do not provide sufficient anticoagulation in APS. Option C (closure of PFO) is not the primary treatment for preventing thromboembolic events in APS, since the hypercoagulability is the primary driver of thrombotic events rather than embolism through a PFO alone. Therefore, Option B (warfarin) is the best management choice for this patient. 1. In APS, always consider long-term anticoagulation as the patient is at high risk for recurrent thrombotic events. 2. Warfarin is the preferred treatment for nonpregnant patients; however, in pregnancy, LMWH with low-dose aspirin is advised. 3. Incidentally found PFOs in the setting of APS do not warrant closure unless they are clearly contributing to embolic events in the absence of a hypercoagulable state. Recent guidelines and clinical evidence continue to advocate for the use of warfarin in patients with APS and documented thrombotic events to reduce the risk of recurrence. Studies have confirmed that maintaining an INR in the target range (typically 2-3) significantly lowers the risk of further thrombosis. In the event of pregnancy, current recommendations favor LMWH over warfarin due to the known teratogenic effects of the latter.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about dermatomyositis (they mentioned pt. With weakness and typical skin lesion, and cough) ??? (Not sure about details and choices) Which antibody:",
    "option_a": "Anti synthetase",
    "option_b": "Anti mda5",
    "option_c": "Anti SRP",
    "option_d": "ANTI TIF",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Dermatomyositis is an idiopathic inflammatory myopathy characterized by proximal muscle weakness and distinctive cutaneous findings such as heliotrope rash and Gottron papules. Its subtypes are partly defined by myositis\u2010specific antibodies, each correlating with different clinical patterns and systemic involvements. An autoimmune process leads to muscle fiber injury and a complement-mediated microangiopathy in the skin. Among the antibodies, the anti-synthetase group (most notably anti-Jo1) targets aminoacyl-tRNA synthetases, fostering an inflammatory cascade that can also involve the lungs and result in interstitial lung disease (ILD). In this scenario, the patient presents with muscle weakness, a classic dermatomyositis skin eruption, and a cough. The presence of cough raises the suspicion for ILD, a well-described feature in patients with anti-synthetase syndrome. Evaluation involves a combination of clinical examination, serum creatine kinase levels, autoantibody panels (examining myositis-specific antibodies including anti-synthetase), electromyography, and often muscle biopsy. In patients with respiratory symptoms, chest imaging (e.g., high-resolution CT scan) is essential to screen for ILD. The mainstay of management is high-dose corticosteroids along with additional immunosuppressive agents (such as methotrexate, azathioprine, or mycophenolate mofetil) to control muscle and lung inflammation. In cases with significant ILD, more aggressive immunomodulatory therapy may be warranted. For pregnant and lactating patients, corticosteroids remain the first-line treatment; however, agents such as methotrexate are contraindicated, so alternative therapies with better safety profiles in pregnancy must be chosen. Option A (Anti-synthetase antibodies) is the best answer in this scenario. Although anti-MDA5 is also associated with ILD, it is more typically seen in clinically amyopathic dermatomyositis with minimal muscle weakness. Anti-SRP is characteristically linked to severe necrotizing myopathy without significant skin manifestations, and anti-TIF1 is more commonly associated with malignancy-related dermatomyositis rather than ILD. The combination of weakness, classic DM rash, and a cough (suggesting ILD) aligns best with an anti-synthetase antibody profile. A cough in a patient with dermatomyositis mandates a thorough evaluation for interstitial lung disease. Identifying the specific autoantibody profile is crucial, as it influences both prognostication and selection of immunosuppressive therapy. Anti-synthetase syndrome, signified by the presence of antibodies such as anti-Jo1, often includes extramuscular manifestations like ILD, arthritis, and mechanic\u2019s hands. Recent research and guidelines emphasize the importance of myositis-specific antibody testing to tailor immunosuppressive therapy. Early detection and management of ILD significantly improve outcomes, and treatment decisions should carefully incorporate patient factors, including pregnancy and lactation, to ensure safety and efficacy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Stab wound with ulnar neuropathy what you will find in NCS after 5 days:",
    "option_a": "Decrease recruitment",
    "option_b": "Fibrillations",
    "option_c": "Insertional activity",
    "option_d": "Complex repetitive discharges",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "After an acute nerve injury such as a stab wound to the ulnar nerve, the muscle fibers begin to show signs of denervation. However, the classical fibrillation potentials that are emblematic of denervation do not typically appear until 10\u201314 days post-injury. Instead, one of the earliest detectable abnormalities on needle electromyography (EMG) is increased insertional activity, which reflects the instability of the muscle membrane when denervated. Following a nerve injury, Wallerian degeneration ensues distal to the lesion. This process leads to impaired neuromuscular transmission and muscle membrane instability. The increased irritability of these denervated fibers results in abnormal electrical discharges upon insertion of the EMG needle. Fibrillation potentials and positive sharp waves, more specific markers of denervation, take time (typically 10\u201314 days) to develop as the full extent of axonal degeneration becomes evident. In the setting of a ulnar nerve injury from a stab wound, patients can present with motor deficits (e.g., weakness in ulnar-innervated hand muscles) and sensory disturbances in the ulnar distribution. Early electrodiagnostic studies (around 5 days post-injury) help localize the lesion and estimate the timing of the nerve injury. The presence of increased insertional activity correlates with acute muscle fiber membrane instability secondary to denervation. The diagnostic evaluation of acute nerve injuries involves both nerve conduction studies (NCS) and needle EMG. While NCS can demonstrate features such as conduction block and reduced compound muscle action potentials, needle EMG is particularly useful in detecting early spontaneous activity. At 5 days post-injury, the key abnormality is increased insertional activity; fibrillation potentials typically emerge after 7\u201314 days. The differential includes distinguishing between neurapraxia (conduction block without axonal loss) and more severe axonotmesis or neurotmesis. Management of acute ulnar neuropathy depends on the severity of the injury. Conservative management, including observation and physical therapy, may be appropriate for neurapraxia, while surgical intervention is considered in cases of axonotmesis or neurotmesis. Pregnancy and lactation considerations are critical; when surgical intervention is necessary, one should use anesthetic and surgical medications that are safe in pregnancy and lactation. In addition, non-teratogenic agents should be chosen and multidisciplinary consultation may be warranted to balance maternal and fetal risks. Option A (Decrease in recruitment) refers to a reduction of motor unit activation on voluntary effort and is less sensitive in the early phase of denervation. Option B (Fibrillations) indeed represents classic signs of denervation but generally are not seen until around 10\u201314 days after the injury, making them less likely at 5 days. Option D (Complex repetitive discharges) are typically associated with chronic changes or reinnervation phenomena. Option C (Insertional activity) is the early abnormal finding on needle EMG attributable to increased muscle fiber irritability shortly after denervation, making it the correct answer. Timing is crucial when interpreting electrodiagnostic studies in nerve injuries. Fibrillation potentials are a late sign (typically emerging after 1\u20132 weeks), whereas increased insertional activity is one of the earliest indicators of denervation. Recognizing the timeline of these findings is essential for accurate diagnosis. Recent neuromuscular and electrodiagnostic literature confirms that the earliest EMG abnormality in acute nerve injury, such as an ulnar neuropathy secondary to a stab wound, is increased insertional activity. This evidence underscores the importance of performing serial studies if initial exams are inconclusive, particularly in the context of early post-trauma evaluation.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about essential myoclonus relieved by alcohol asking about dx.",
    "option_a": "Cortical myoclonus",
    "option_b": "Essential myoclonus",
    "option_c": "Physiological myoclonus",
    "option_d": "Epileptic myoclonus",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Essential myoclonus is an idiopathic movement disorder in which the patient exhibits involuntary, brief, shock\u2010like muscle contractions (myoclonic jerks) in the absence of other neurological abnormalities. Although the term \u2018essential tremor\u2019 is more widely recognized, there is a subset of patients who experience predominantly myoclonic jerks that can be termed as 'essential' if no secondary cause is identified. The underlying mechanism is thought to involve abnormal hyperexcitability in the relevant motor circuits\u2014often at the level of the sensorimotor cortex or subcortical structures\u2014with a disturbance in inhibitory neurotransmission. Unlike epileptic or cortical myoclonus (where discrete electrophysiologic abnormalities and often EEG correlates are noted), essential myoclonus lacks any structural lesion and is presumed to be due to a dysfunction in motor regulation. Although not as well characterized as essential tremor, some patients report improvement with alcohol, which is believed to temporarily modulate GABA\u2010ergic tone. Patients typically present with isolated myoclonic jerks that may be action-induced or present at rest. A notable clinical feature is the improvement of symptoms with the intake of alcohol, which also serves as a supportive clue in the diagnosis. Importantly, these patients do not exhibit other neurological deficits, and their workup (including imaging and routine EEG) is usually unremarkable. Workup generally includes a thorough clinical examination, neurophysiological studies such as EMG (which can help differentiate among different types of myoclonus), and sometimes EEG for ruling out epileptic phenomena. Differential diagnoses include cortical or epileptic myoclonus (which are associated with abnormal EEG changes), physiological myoclonus (a normal variant seen in sleep or benign fasciculations), and secondary causes of myoclonus (such as metabolic or toxic states). Management is largely symptomatic. First-line treatment options include medications such as clonazepam, valproate, or levetiracetam. Since alcohol may transiently improve symptoms, its effect supports the diagnosis but alcohol is not recommended as a treatment strategy. In women who are pregnant or lactating, benzodiazepines and levetiracetam may be used with caution after weighing the risks and benefits, whereas valproate is generally contraindicated due to its teratogenicity. Option A (Cortical myoclonus) typically implies an epileptic or neurodegenerative process with characteristic EEG findings, which is not the case here. Option C (Physiological myoclonus) represents normal, benign phenomena (e.g., sleep or hiccups) that are transient and do not present as a persistent syndrome. Option D (Epileptic myoclonus) would be accompanied by other seizure-related phenomena and abnormal EEG discharges. Thus, Option B (Essential myoclonus) fits best given the isolated, alcohol-responsive nature of the myoclonic jerks. 1. Alcohol responsiveness is a key supportive feature in disorders falling under the 'essential' category (as seen in essential tremor and, less commonly, essential myoclonus). 2. Differentiating between cortical/epileptic myoclonus and essential myoclonus is crucial; the absence of EEG abnormalities and other neurological signs points toward an essential, idiopathic process. Recent research emphasizes the role of dysfunctional inhibitory neurotransmission in idiopathic movement disorders. While essential tremor is much better characterized in clinical studies, evolving neurophysiological techniques continue to refine our understanding of less common presentations such as essential myoclonus. Guidelines still recommend symptomatic therapy with agents that enhance GABAergic transmission with special consideration for women of childbearing potential.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "IV drug user came with acute stroke in 2 hours, CT image attached (good aspect) Was febrile and had a pan systolic murmur. What is the treatment?",
    "option_a": "antibiotics",
    "option_b": "thrombolysis",
    "option_c": "thrombectomy",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In patients with acute ischemic stroke, treatment is usually time sensitive. However, in the context of infective endocarditis, which is a well-known source of septic emboli, the management approach differs considerably compared to atherosclerotic strokes. Infective endocarditis, particularly in IV drug users, predisposes to the formation of infected vegetations on heart valves. Embolization of these vegetations can lead to ischemic strokes. Unlike typical thromboembolic strokes from atherosclerosis or cardiac mural thrombi, septic emboli carry a risk of causing hemorrhagic conversion and mycotic aneurysms. The patient\u2019s history of intravenous drug use, the presence of fever, and a pan\u2010systolic murmur strongly point towards infective endocarditis as the underlying etiology of the stroke. In such cases, rapid identification and treatment of the infection are paramount to prevent further embolic events and complications. The diagnostic workup in such cases includes blood cultures, echocardiography (transthoracic and/or transesophageal) to identify vegetations on the valves, as well as neuroimaging (CT or MRI) to assess the nature of the stroke. Differential diagnoses include atherosclerotic stroke, cardioembolic stroke from atrial fibrillation, or hemorrhagic stroke. The clinical context and imaging help distinguish septic embolism secondary to endocarditis from these other types. The primary treatment is the initiation of appropriate intravenous antibiotics tailored to the suspected or identified organism (often covering Staphylococcus aureus in IV drug users). Thrombolysis is contraindicated in infective endocarditis due to the high risk of intracranial hemorrhage and potential worsening of the septic embolic phenomenon. In cases of large vessel occlusion where mechanical thrombectomy is considered, careful evaluation is needed and generally, thrombectomy is not the first-line treatment if an infection is present. In pregnant or lactating patients, antibiotic selection should consider fetal safety, with agents such as penicillins or cephalosporins often preferred. Option A (antibiotics) is the appropriate treatment given the clinical scenario of presumed infective endocarditis causing septic emboli. Option B (thrombolysis) is contraindicated in the setting of infective endocarditis. Option C (thrombectomy) is not routinely indicated in septic embolic strokes because of the risk of infecting the cerebral vasculature and provoking hemorrhage. Option D is missing and thus not applicable. 1. In a febrile patient with IV drug use and a new murmur, always suspect infective endocarditis as a source of embolic stroke. 2. Thrombolysis is contraindicated in infective endocarditis because of the increased risk of hemorrhagic conversion. Recent guidelines emphasize the need for rapid antibiotic administration in infective endocarditis and caution against the use of thrombolytic therapy in septic embolic strokes due to bleeding risks. Research continues to refine the management strategies in these complex patients, particularly regarding the timing of surgical interventions if indicated.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Stroke and diagnosed with acute ischemic stroke, patient undergone work up and her vessels imaging showed atherosclerotic disease however no critical stenosis, ECHO is normal except for an EF of 55%, 8-hour Holter did not show any arrhythmia, HBA1C and lipid profile was accepted. What is the most likely mechanism of her stroke?",
    "option_a": "embolism (most likely it wasn\u2019t clear)",
    "option_b": "hypoperfusion",
    "option_c": "vessel stenosis",
    "option_d": "thrombosis",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Acute ischemic stroke has several potential mechanisms, including embolic, thrombotic (in situ), hypoperfusion, or due to severe vessel stenosis. When routine investigations fail to reveal a high-grade source, the etiology may be classified as embolic or cryptogenic. Embolic strokes occur when an embolus, originating from the heart or another source, occludes a cerebral artery. In some patients, particularly those who lack identifiable causes like atrial fibrillation, high-grade arterial stenosis, or cardiac thrombi, the stroke is considered embolic in nature\u2014often termed an embolic stroke of undetermined source (ESUS). The described patient has evidence of atherosclerotic disease but no critical stenosis, a normal echocardiogram with preserved ejection fraction, and no arrhythmias on prolonged monitoring. These findings support the likelihood of an embolic event where the source remains unclear, fitting the profile of a cryptogenic embolism. A comprehensive evaluation includes vascular imaging (Doppler ultrasound, CT/MR angiography) to look for significant stenoses, cardiac investigations (echocardiography, Holter monitoring) to search for embolic sources, and laboratory assessments for thrombophilia. Differential diagnoses include hypoperfusion-related strokes (which typically occur in watershed zones) and in situ thrombosis over a ruptured plaque, but the workup in this case points away from these causes. Current guidelines recommend antiplatelet therapy (e.g., aspirin) as the mainstay for secondary prevention in ESUS, along with aggressive management of vascular risk factors. Although clinical trials have investigated the role of direct oral anticoagulants for ESUS, antiplatelet therapy remains standard unless a clear embolic source is subsequently identified. In pregnant or lactating patients, low-dose aspirin is generally considered safe for stroke prevention. Option A (embolic mechanism) is most consistent with the workup findings and the clinical scenario (i.e., an embolic stroke of undetermined source). Option B (hypoperfusion) usually produces watershed infarcts and is associated with systemic hypotension. Option C (vessel stenosis) is less likely given the imaging did not reveal critical stenosis, and Option D (thrombosis from a local clot) is less favored when embolic sources are more likely even if occult. 1. ESUS should be considered when a stroke appears embolic but no high\u2010grade stenosis or cardiac source is identified after a comprehensive evaluation. 2. Management of ESUS focuses on secondary prevention with antiplatelet therapy and risk factor modification. Recent clinical trials have explored the role of anticoagulants in ESUS, but current guidelines continue to recommend antiplatelet agents as first-line therapy. Ongoing research may eventually refine the approach, especially in patients with subtle prothrombotic tendencies.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "short scenario with attached image of NCS showing drop of amplitude:",
    "option_a": "Conduction block",
    "option_b": "Temporal dispersion",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Nerve conduction studies (NCS) evaluate the integrity of peripheral nerves. A key parameter is the amplitude of the compound muscle action potential (CMAP). A significant drop in amplitude across a segment of the nerve suggests that many axons are not contributing normally, often because of a conduction block. Conduction block occurs when demyelination or other pathologic processes prevent the consistent propagation of the nerve impulse across a segment of a nerve. This results in a reduction of the recorded CMAP amplitude distal to the lesion. Temporal dispersion, on the other hand, is characterized by prolonged duration of the CMAP due to variable slowing among individual nerve fibers, which tends to smear out the waveform rather than simply reduce its amplitude. In conditions such as multifocal motor neuropathy or in some forms of demyelinating neuropathies, conduction block is a key electrophysiological finding that correlates with segmental demyelination. The patient\u2019s nerve conduction study demonstrating a drop in amplitude is highly suggestive of a conduction block. Interpretation of NCS involves comparing amplitude, conduction velocity, and waveform morphology. Differential considerations include temporal dispersion (which shows waveform broadening rather than isolated amplitude reduction) and axonal loss (which may also reduce amplitude but tends to affect the entire nerve rather than in a focal block). Management of conditions showing conduction block depends on the underlying cause. In multifocal motor neuropathy, for example, treatment with intravenous immunoglobulin (IVIg) is first-line. Corticosteroids are typically ineffective or may worsen the condition. In pregnancy or lactation, IVIg is generally considered safe and is often used as a treatment modality for immune-mediated neuropathies. Option A (Conduction block) is correct since the drop in amplitude on NCS is most indicative of this phenomenon. Option B (Temporal dispersion) would be characterized by a waveform with increased duration and not solely a drop in amplitude. Options C and D are not provided, making them non-applicable. 1. A focal drop in CMAP amplitude with preserved conduction velocity across other segments is highly suggestive of a conduction block. 2. Differentiating conduction block from temporal dispersion is essential as the management and prognosis of demyelinating versus axonal neuropathies differ. Recent electrophysiological studies and guidelines continue to stress the importance of distinguishing conduction block from other NCS abnormalities. In immune-mediated neuropathies, early identification of conduction block facilitates timely treatment, with IVIg being supported by robust evidence and considered safe even during pregnancy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "36-year-old patient who present with memory complaint and visual-spatial defect what is the responsible gene (Alzheimer scenario):",
    "option_a": "TREM",
    "option_b": "ubiquitin",
    "option_c": "EPO4",
    "option_d": "APP",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Alzheimer\u2019s disease (AD) is a neurodegenerative disorder characterized by progressive memory loss, changes in language and visuospatial function, and other cognitive deficits. In familial (early\u2010onset) AD, specific gene mutations such as those in the amyloid precursor protein (APP) gene drive the pathology. This question, describing a 36\u2010year\u2010old with memory and visuospatial complaints, points toward an early-onset Alzheimer\u2019s picture where mutations in the APP gene are implicated. Mutations in the APP gene result in abnormal processing of the amyloid precursor protein, leading to an overproduction or improper formation of beta-amyloid peptides. These peptides aggregate extracellularly into plaques which, along with neurofibrillary tangles composed of hyperphosphorylated tau protein, contribute to neurodegeneration. Current evidence supports that this cascade of events triggers synaptic dysfunction, oxidative stress, and neuronal death. Patients with early-onset AD typically present with cognitive deficits including memory impairment and difficulty with visuospatial tasks (which may manifest as problems with navigation or recognizing objects/people). Familial AD that involves APP mutations may present earlier than typical sporadic cases and follow an autosomal dominant inheritance pattern. The diagnosis is based on clinical evaluation, cognitive testing, and neuroimaging. Differential diagnoses include frontotemporal dementia, vascular dementia, and other neurodegenerative disorders. In familial cases, genetic testing for APP mutations (as well as presenilin 1 and 2 mutations) can support the diagnosis. Management is primarily symptomatic with cholinesterase inhibitors (e.g., donepezil, rivastigmine) and NMDA receptor antagonists (e.g., memantine). While there is no cure, supportive care and cognitive therapy are added. In the context of pregnancy and lactation, these medications are used with caution. Genetic counseling is recommended for familial cases. Ongoing research into beta-amyloid-targeting immunotherapies is being pursued, although these are not yet standard care. Option A (TREM) refers to genes like TREM2, which while associated with an increased risk of AD, are not typically the causative mutation in early-onset familial Alzheimer\u2019s. Option B (ubiquitin) and C (EPO4) are not implicated as causal mutations in AD. Option D (APP) is the gene directly responsible when mutated in early-onset familial Alzheimer\u2019s, making it the correct answer. 1. Early-onset familial Alzheimer\u2019s disease often involves mutations in APP, PSEN1, or PSEN2 and presents at a much younger age than sporadic AD. 2. Visuospatial deficits can be an early sign in certain variants of AD (eg, posterior cortical atrophy). Recent studies continue to elucidate the role of APP processing in AD pathogenesis, and emerging immunotherapies targeting beta-amyloid are under investigation. Genetic testing remains an important tool in diagnosing familial cases, with updated guidelines recommending counseling for affected families.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Essential tremor scenario with asthma rx;",
    "option_a": "Primidone",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Essential tremor (ET) is one of the most common movement disorders, clinically manifesting as a postural or action tremor affecting the hands and sometimes the head. First-line treatment options typically include non-selective beta-blockers (eg, propranolol) and primidone (a barbiturate). The underlying mechanism of essential tremor is not fully understood, but it is thought to involve abnormal oscillatory activity in the cerebellothalamocortical circuit. This leads to involuntary rhythmic contractions of muscles during voluntary movement or when maintaining a posture. ET typically presents with bilateral action tremor that worsens with intentional movement. When a patient also has a comorbidity such as asthma, the use of non-selective beta-blockers may exacerbate bronchospasm, thereby making primidone the preferred treatment. Diagnosis is clinical, based on history and physical examination. Differential diagnoses include Parkinson\u2019s disease (characterized by rest tremor), dystonic tremor, and tremor from hyperthyroidism. A detailed history can help distinguish ET from these conditions. For essential tremor, first-line therapy is often propranolol; however, in patients with contraindications such as asthma, primidone becomes the treatment of choice. Second-line treatments include topiramate and gabapentin. In pregnancy and lactation, primidone must be used with caution due to potential teratogenic effects; however, if needed, it may be used with careful risk-benefit analysis and under close monitoring. Option A (Primidone) is correct because it avoids the bronchoconstrictive effects seen with beta-blockers in patients with asthma. The absence of other options reinforces that primidone is the best choice for ET in the setting of asthma. 1. Essential tremor is typically an action or postural tremor and is often familial. 2. Beta-blockers are contraindicated in patients with reactive airway disease such as asthma. Recent guidelines continue to support primidone as an effective treatment for essential tremor, particularly in patients who cannot tolerate beta-blockers. Ongoing research into the cerebellothalamocortical circuits may further clarify the pathophysiological basis of ET and lead to novel therapeutic targets.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of old pt. Had stroke and became hyperactive, flight of ideas and pressured speech (mania) where will expect the lesion:",
    "option_a": "Caudate",
    "option_b": "Thalamus",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Secondary mania following a cerebrovascular accident is a recognized clinical phenomenon. It can occur when a stroke affects brain regions involved in mood regulation. This case describes an elderly patient who developed hyperactivity, flight of ideas, and pressured speech (core features of mania) after a stroke. Disruption of neural circuits, particularly within the frontal\u2013subcortical pathways, can lead to disinhibition and mood dysregulation. Lesions in the basal ganglia, especially the caudate nucleus, have been implicated in secondary mania due to their role in modulating emotional processing and executive function. Post-stroke mania is uncommon but has been associated with lesions in right hemispheric structures. The caudate nucleus plays a key role in behavioral modulation, and its injury can result in symptoms resembling a manic episode, as seen in the case. Evaluation includes a detailed neuropsychiatric assessment in the context of recent stroke. Differential diagnoses include primary bipolar disorder, medication-induced mood changes, and other post-stroke mood disorders. Neuroimaging (CT/MRI) aids in localizing the lesion and correlating it with clinical findings. Management of post-stroke mania involves stabilization using mood stabilizers (eg, lithium or valproic acid) and atypical antipsychotics. Tailoring treatment in the elderly is crucial, given the increased risk of adverse effects. In pregnancy or lactation, mood stabilizer choice requires careful risk assessment: for example, lithium may be considered with appropriate monitoring while valproate is generally avoided due to teratogenicity. Option A (Caudate) is correct because lesions in the caudate nucleus, particularly in the right hemisphere, have been linked to secondary mania after stroke. Option B (Thalamus) is also in the region of interest but is less commonly cited as the primary site responsible for manic symptoms in post-stroke presentations, making the caudate the better answer here. Missing options (C and D) do not affect the correctness of the selection. 1. Post-stroke mania is a rare but recognized syndrome associated with lesions in the frontal\u2013subcortical circuits, particularly the caudate. 2. Always consider a vascular etiology when new-onset mood changes occur in the elderly following a stroke. Recent reviews and case series have reinforced the link between right caudate lesions and the development of mania post-stroke. Neuroimaging studies continue to clarify the involvement of basal ganglia circuits in mood regulation, aiding both diagnosis and management.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario for GCA what is the most likely mechanism (or artery):",
    "option_a": "Posterior ciliary artery",
    "option_b": "RCAO",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Giant Cell Arteritis (GCA) is a systemic vasculitis affecting large and medium-sized arteries, notably those branching from the carotid artery. A critical complication of GCA is vision loss resulting from ischemia of the optic nerve. In GCA, inflammatory infiltration of the arterial wall leads to intimal thickening and luminal narrowing. When this process affects the posterior ciliary arteries, which supply the optic nerve head, it can lead to anterior ischemic optic neuropathy and subsequent visual impairment. This mechanism is central to the pathogenesis of vision loss in GCA. Patients with GCA often present with new-onset headache, jaw claudication, visual disturbances, and systemic symptoms such as fever and weight loss. The involvement of the posterior ciliary arteries is what typically results in the sight-threatening complications seen in GCA. The diagnosis is based on a combination of clinical features, elevated inflammatory markers (ESR and CRP), and confirmatory temporal artery biopsy. Differential diagnoses include other vasculitides, non-arteritic anterior ischemic optic neuropathy, and other causes of sudden vision loss. Prompt recognition is essential given the risk of irreversible blindness. First-line treatment for GCA is high-dose corticosteroids, initiated immediately upon suspicion to mitigate the risk of blindness. The use of adjunctive therapies such as low-dose aspirin is common. Newer agents like tocilizumab (an IL-6 receptor inhibitor) have shown promise in recent trials. In pregnant patients, corticosteroids are used when clearly indicated, balancing the maternal benefits against fetal risks, and during lactation, the risk is minimized with careful monitoring. Option A (Posterior ciliary artery) is correct because occlusion or inflammation of these arteries is the primary mechanism leading to visual loss in GCA. Option B (RCAO, likely referring to a central retinal artery occlusion variant) is not the typical mechanism in GCA; the pathology primarily involves the posterior ciliary circulation. Options C and D are not provided, making Option A the best choice. 1. Immediate high-dose corticosteroids are crucial in GCA to prevent permanent vision loss. 2. The posterior ciliary arteries are the key vascular structures whose compromise leads to anterior ischemic optic neuropathy in GCA. Recent guidelines and large trials, including the GiACTA trial, have supported the use of tocilizumab as an effective adjunctive treatment to steroids in GCA. Emphasis remains on early identification and treatment to prevent complications such as blindness, and ongoing research continues to refine optimal management strategies.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Giant cell arteritis what is next:",
    "option_a": "Steroid",
    "option_b": "biopsy",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Giant cell arteritis (GCA) is a systemic large\u2010vessel vasculitis primarily affecting the temporal arteries in older adults. It is characterized by headache, jaw claudication, scalp tenderness, and a high risk of vision loss due to ischemic complications. GCA involves granulomatous inflammation with the presence of giant cells in the arterial wall. This leads to luminal narrowing, impaired blood flow, and subsequent ischemia of tissues supplied by affected vessels (notably the optic nerve, which can lead to permanent vision loss). Patients typically present with new-onset headache, jaw claudication, visual disturbances, and sometimes systemic symptoms such as fever and weight loss. Elevated inflammatory markers (ESR, CRP) further support the clinical suspicion. Delay in treatment can result in irreversible complications such as blindness. The diagnosis is supported by clinical findings and laboratory tests. While a temporal artery biopsy is the gold standard for confirmation, it should be performed after initiating treatment because delaying steroids can lead to permanent damage. Key differentials include polymyalgia rheumatica and other vasculitides. First-line management for suspected GCA is immediate initiation of high-dose corticosteroids (e.g., prednisone 40-60 mg daily, or IV steroids if there is imminent vision threat). Temporal artery biopsy should be arranged within 1-2 weeks of starting therapy. In select cases, steroid\u2010sparing agents like Tocilizumab are used. Although rare in pregnancy, if encountered, the benefits of steroid use must be weighed against potential risks to the fetus. Option A (Steroid) is correct because immediate steroid administration is essential to prevent irreversible complications such as vision loss. Option B (Biopsy), although important for definitive diagnosis, should not delay the initiation of steroids. 1. In suspected GCA, never delay high-dose steroids, as time is vision. 2. Temporal artery biopsy confirms the diagnosis but can be performed after starting steroids. 3. Always check inflammatory markers (ESR/CRP) to support the clinical picture. Recent guidelines emphasize urgent treatment with high-dose steroids in suspected GCA to mitigate the risk of blindness. Additionally, newer studies support the adjunctive use of biologics like Tocilizumab, particularly in steroid-dependent cases.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of young female with picture of 2 attacks and 2 objective findings came with new relapse of sudden left-sided weakness for 5 days after hx of exhaustion what to do: (or scenario of clinical isolated syndrome not sure)",
    "option_a": "Start fingolimod",
    "option_b": "Start interferon",
    "option_c": "Emergent pulse steroid",
    "option_d": "MRI brain",
    "option_e": "MRI?",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Multiple sclerosis (MS) is a chronic autoimmune demyelinating disorder that typically affects young adults, especially females. The condition is marked by episodes of neurological dysfunction (relapses) interspersed with periods of recovery (remission). MS pathogenesis involves T-cell mediated immune responses that target the myelin sheath of central nervous system neurons, resulting in discrete areas of demyelination (plaques). Relapses may be triggered by fatigue, stress, or infections, leading to new inflammatory lesions. The patient\u2019s history of multiple attacks with objective findings fulfills the criteria for dissemination in time and space. The new onset of sudden left-sided weakness after an exhausting episode suggests an acute relapse, for which prompt therapy is essential to curb inflammatory demyelination and expedite recovery. Magnetic resonance imaging (MRI) of the brain and spinal cord with gadolinium is the gold standard for detecting new or active lesions in MS. Although imaging is important for disease monitoring, clinical management of an acute relapse should not be delayed pending MRI findings. For acute relapses, the first-line therapy is high-dose intravenous methylprednisolone (typically 1 gram daily for 3-5 days). Disease-modifying therapies (e.g., interferon beta, fingolimod) are used for long-term management, not for immediate relapse treatment. In pregnancy, pulse steroids may be used after a careful risk-benefit analysis, and many long-term disease-modifying drugs are contraindicated. Option C (Emergent pulse steroid) is correct as immediate treatment with high-dose corticosteroids is the standard of care for acute MS relapses. Options A and B (starting fingolimod or interferon) are intended for long-term disease modification rather than acute management, and options D/E (MRI) are important diagnostically but do not address the need for prompt relapse treatment. 1. In MS, always use high-dose IV steroids to manage acute relapses. 2. MRI is crucial for diagnosis and monitoring but should not delay urgent treatment. 3. Long-term disease-modifying therapies are separate from acute relapse management. Recent studies and guidelines continue to support the use of high-dose IV corticosteroids for acute relapses, emphasizing rapid intervention to minimize irreversible neurological damage. There is ongoing research into refining dosing regimens and exploring the safe use of steroids during pregnancy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A pediatric patient who presented with expansile spinal cord signal changes with partial enhancement:",
    "option_a": "Astrocytoma",
    "option_b": "Ependymoma",
    "option_c": "Hemangioma",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In pediatric patients, intramedullary spinal tumors are relatively uncommon, with astrocytomas being the most frequently encountered type. These tumors tend to present with cord expansion and mixed signal characteristics on MRI. Spinal astrocytomas originate from glial cells and are often infiltrative in nature. Their growth leads to expansion of the spinal cord with patchy or partial contrast enhancement, reflecting their heterogeneous cellular makeup. Pediatric patients with spinal astrocytomas may present with progressive neurological deficits such as motor weakness or sensory changes. The MRI finding of an expansile lesion with partial enhancement is a typical radiologic appearance for this type of tumor, as opposed to more well-circumscribed lesions seen with ependymomas. MRI is the imaging modality of choice to evaluate intramedullary lesions in the spinal cord. Differentials include ependymoma (often more common in adults and showing homogeneous enhancement) and, less commonly, hemangioma. Clinical context (age, presentation) is crucial in differentiating these conditions. The mainstay of treatment is surgical resection with the goal of maximal safe removal while preserving neurological function. Adjuvant radiation or chemotherapy may be considered in cases where the tumor is incompletely resectable or high grade. For patients who are pregnant, management requires multidisciplinary discussion to balance maternal and fetal risks, with non-emergent surgeries potentially delayed or modified. Option A (Astrocytoma) is correct because it represents the most common type of intramedullary spinal tumor in children with the described imaging characteristics. Option B (Ependymoma) is more typical in adults, and Option C (Hemangioma) is relatively uncommon in this clinical context. 1. Pediatric intramedullary spinal tumors are most often astrocytomas. 2. Expansile lesions with partial enhancement on MRI are characteristic of astrocytomas in children. 3. Early diagnosis with MRI is vital for planning appropriate surgical management. Recent advances focus on improved surgical techniques and targeted therapies for pediatric spinal astrocytomas, with studies evaluating the role of molecular markers in guiding prognosis and treatment strategies.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Vague scenario of pt. With no hx available because no family around brought to ER with decrease level of consciousness and fever (not mentioned rigidity) ct brain and csf normal what to do:",
    "option_a": "Dantrolene",
    "option_b": "Acyclovir",
    "option_c": "Antibiotics",
    "option_d": "Toxicity screening",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This scenario describes a patient with decreased level of consciousness and fever. Even with normal CT imaging and CSF studies initially, there must be a high index of suspicion for central nervous system infections such as herpes simplex encephalitis (HSE). HSV encephalitis typically involves the temporal lobes and leads to inflammation, edema, and potential necrosis of brain tissue. Early in the course, diagnostic studies including CT and CSF analysis can be deceptively normal, yet the viral replication and immune response are actively causing neuronal injury. The patient\u2019s presentation with fever and altered mental status, even in the absence of meningeal signs (such as rigidity), raises concern for HSE. Early diagnosis is crucial since delays significantly worsen outcomes. The diagnostic workup for suspected HSE includes lumbar puncture with PCR for HSV, electroencephalography (EEG), and potentially repeat imaging. Differential diagnoses include bacterial meningitis (usually with marked CSF abnormalities), toxic/metabolic encephalopathies, and other viral encephalitides. The mainstay of management is the immediate initiation of intravenous acyclovir. Guidelines recommend starting acyclovir empirically in any suspected case of HSE, regardless of initial imaging or CSF findings, due to the high risk of morbidity and mortality. In pregnant or lactating women, acyclovir is generally considered safe when used after evaluating the risks and benefits. Empiric antibiotic coverage may also be instituted if bacterial causes are considered, but acyclovir remains critical. Option B (Acyclovir) is correct because it targets HSV promptly, which is crucial even when early diagnostic tests are normal. Option A (Dantrolene) is used for conditions like neuroleptic malignant syndrome, Option C (Antibiotics) is more applicable to bacterial infections (which typically would alter CSF findings), and Option D (Toxicity screening) does not address a treatable infectious process. 1. Always initiate acyclovir in cases of suspected HSV encephalitis without waiting for confirmatory tests. 2. Early treatment is associated with better neurological outcomes. 3. Normal early CT and CSF results do not exclude the diagnosis of HSE. Current guidelines stress that the decision to begin acyclovir should be made on clinical suspicion alone, as studies have shown that delays in treatment are associated with worse outcomes. Recent research also explores adjunctive therapies and improved diagnostic algorithms to identify early cases of HSE more effectively.",
    "exam_year": "2020",
    "exam_type": "Part II"
  }
]